Treatment of Cow's Milk Protein Allergy

Research output: Contribution to journalScientific reviewpeer-review

30 Citations (Scopus)


The diagnosis and treatment of cow's milk protein allergy (CMPA) is still a challenge. A systematic literature search was performed using Embase, Medline, The Cochrane Database of Systematic Reviews and Cochrane Central Register of Controlled Clinical Trials for the diagnosis and treatment of cow's milk allergy (CMA). Since none of the symptoms of CMPA is specific and since there is no sensitive diagnostic test (except a challenge test), the diagnosis of CMPA remains difficult. A "symptom-based score" is useful in children with symptoms involving different organ systems. The recommended dietary treatment is an extensive cow milk based hydrolysate. Amino acid based formula is recommended in the most severe cases. However, soy infant formula and hydrolysates from other protein sources (rice) are gaining popularity, as they taste better and are cheaper than the extensive cow's milk based hydrolysates. Recent meta-analyses confirmed the safety of soy and estimate that not more than 10-15% of CMPA-infants become allergic to soy. An accurate diagnosis of CMA is still difficult. The revival of soy and the development of rice hydrolysates challenge the extensive cow's milk based extensive hydrolysates as first option and amino acid formula.

Original languageEnglish
Pages (from-to)1-5
Number of pages5
JournalPediatr Gastroenterol Hepatol Nutr
Issue number1
Publication statusPublished - 2014


  • Cow's milk protein allergy
  • Infant


Dive into the research topics of 'Treatment of Cow's Milk Protein Allergy'. Together they form a unique fingerprint.

Cite this